158 related articles for article (PubMed ID: 17389005)
1. Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis.
Vigen C; Hodis HN; Chandler WL; Lobo RA; Mack WJ
J Thromb Haemost; 2007 Jun; 5(6):1201-8. PubMed ID: 17389005
[TBL] [Abstract][Full Text] [Related]
2. Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.
Lindoff C; Peterson F; Lecander I; Martinsson G; Astedt B
Maturitas; 1996 May; 24(1-2):43-50. PubMed ID: 8794433
[TBL] [Abstract][Full Text] [Related]
3. Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial.
Mack WJ; Hameed AB; Xiang M; Roy S; Slater CC; Stanczyk FZ; Lobo RA; Liu CR; Liu CH; Hodis HN
Atherosclerosis; 2003 May; 168(1):91-8. PubMed ID: 12732391
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT).
Hwang J; Mack WJ; Xiang M; Sevanian A; Lobo RA; Hodis HN
Atherosclerosis; 2005 Aug; 181(2):375-80. PubMed ID: 16039293
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.
Karim R; Hodis HN; Stanczyk FZ; Lobo RA; Mack WJ
J Clin Endocrinol Metab; 2008 Jan; 93(1):131-8. PubMed ID: 17925335
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone replacement therapy on hemostatic cardiovascular risk factors.
Andersen LF; Gram J; Skouby SO; Jespersen J
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):283-9. PubMed ID: 9988788
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN.
Sowers M; Derby C; Jannausch ML; Torrens JI; Pasternak R
J Clin Endocrinol Metab; 2003 Oct; 88(10):4904-10. PubMed ID: 14557472
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study.
Post MS; van der Mooren MJ; van Baal WM; Blankenstein MA; Merkus HM; Kroeks MV; Franke HR; Kenemans P; Stehouwer CD
Am J Obstet Gynecol; 2003 Nov; 189(5):1221-7. PubMed ID: 14634544
[TBL] [Abstract][Full Text] [Related]
10. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.
Hodis HN; Mack WJ; Lobo RA; Shoupe D; Sevanian A; Mahrer PR; Selzer RH; Liu Cr CR; Liu Ch CH; Azen SP;
Ann Intern Med; 2001 Dec; 135(11):939-53. PubMed ID: 11730394
[TBL] [Abstract][Full Text] [Related]
11. Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women.
Basurto L; Saucedo R; Zárate A; Martínez C; Gaminio E; Reyes E; Hernandez M
Gynecol Obstet Invest; 2006; 61(2):61-4. PubMed ID: 16192735
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
Spona J; Feichtinger W; Kindermann C; Schneider B; Mellinger U; Walter F; Moore C; Gräser T
Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
[TBL] [Abstract][Full Text] [Related]
13. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
Hodis HN; Mack WJ; Henderson VW; Shoupe D; Budoff MJ; Hwang-Levine J; Li Y; Feng M; Dustin L; Kono N; Stanczyk FZ; Selzer RH; Azen SP;
N Engl J Med; 2016 Mar; 374(13):1221-31. PubMed ID: 27028912
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic factors and estrogen during the menopausal transition.
Sowers MR; Matthews KA; Jannausch M; Randolph JF; McConnell D; Sutton-Tyrrell K; Little R; Lasley B; Pasternak R
J Clin Endocrinol Metab; 2005 Nov; 90(11):5942-8. PubMed ID: 16105968
[TBL] [Abstract][Full Text] [Related]
15. Differential Effect of Plasma Estradiol on Subclinical Atherosclerosis Progression in Early vs Late Postmenopause.
Sriprasert I; Hodis HN; Karim R; Stanczyk FZ; Shoupe D; Henderson VW; Mack WJ
J Clin Endocrinol Metab; 2019 Feb; 104(2):293-300. PubMed ID: 30272234
[TBL] [Abstract][Full Text] [Related]
16. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O
Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753
[TBL] [Abstract][Full Text] [Related]
17. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial.
El Khoudary SR; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman M; Naftolin F; Hodis HN; Brinton EA; Miller VM; Taylor HS; Budoff MJ
Menopause; 2020 Mar; 27(3):255-262. PubMed ID: 32015261
[TBL] [Abstract][Full Text] [Related]
18. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.
Hodis HN; Mack WJ; Shoupe D; Azen SP; Stanczyk FZ; Hwang-Levine J; Budoff MJ; Henderson VW
Menopause; 2015 Apr; 22(4):391-401. PubMed ID: 25380275
[TBL] [Abstract][Full Text] [Related]
19. Effect of menopausal hormone therapy on arterial wall echomorphology: Results from the Early versus Late Intervention Trial with Estradiol (ELITE).
Karim R; Xu W; Kono N; Sriprasert I; Li Y; Yan M; Stanczyk FZ; Shoupe D; Mack WJ; Hodis HN
Maturitas; 2022 Aug; 162():15-22. PubMed ID: 35474254
[TBL] [Abstract][Full Text] [Related]
20. Treatment with a GnRH analogue: effects on hemostatic risk factors for thrombo-embolic disease.
Lindoff C; Petersson F; Samsioe G; Astedt B
Int J Fertil Menopausal Stud; 1994; 39(3):133-9. PubMed ID: 7920748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
